URESP, Centre de recherche FRSQ du CHA universitaire de Québec, Quebec City, Quebec, Canada.
Psychooncology. 2012 Oct;21(10):1071-81. doi: 10.1002/pon.2003. Epub 2011 Jun 21.
Data on the impact of abnormal cervical smear results on health-related quality of life (HrQoL) are scarce. We aimed to (i) prospectively assess the HrQoL of women who were informed of an abnormal smear result; (ii) identify predictors of greater negative psychosocial impact of an abnormal result; and (iii) prospectively estimate the quality-adjusted life-years (QALYs) lost following an abnormal result.
Between 08/2006 and 08/2008, 492 women with an abnormal result and 460 women with a normal result, frequency matched for age and clinic, were recruited across Canada. HrQoL was measured at recruitment and 4 and 12 weeks later with the EuroQol, Short Form-12, short Spielberg State-Trait Anxiety Inventory (STAI) and HPV Impact Profile. Three blocks of potential predictors of higher psychosocial impact were tested by hierarchical modeling: (i) socio-demographics; (ii) sexual activity; and (iii) smear result severity, communication, and understanding.
Receiving an abnormal result significantly increased anxiety (STAI mean difference between both groups = 8.3). Initial anxiety decreased over time for the majority of women. However, 35% of women had clinically meaningful anxiety at 12 weeks (i.e. STAI scores ≥0.5 standard deviation of the controls). These women reported a lower socio-economic level, did not completely understand the information about their result and perceived themselves at higher risk of cancer. QALY lost following an abnormal result were between 0.007 and 0.009.
Receiving an abnormal smear has a statistically significant and clinically meaningful negative impact on mental health. However, this negative impact subsides after 12 weeks for the majority of women.
关于异常宫颈涂片结果对健康相关生活质量(HrQoL)影响的数据很少。我们的目的是:(i)前瞻性评估通知异常涂片结果的女性的 HrQoL;(ii)确定异常结果产生更大负面影响的预测因素;(iii)前瞻性估计异常结果后质量调整生命年(QALYs)的损失。
2006 年 8 月至 2008 年 8 月期间,在加拿大各地招募了 492 名异常结果的女性和 460 名正常结果的女性,按照年龄和诊所进行频率匹配。在招募时以及 4 周和 12 周后使用 EuroQol、简短形式 12、短 Spielberg 状态特质焦虑量表(STAI)和 HPV 影响概况来测量 HrQoL。通过层次建模测试了三个潜在预测因素块对更高心理社会影响的影响:(i)社会人口统计学;(ii)性行为;(iii)涂片结果的严重程度、沟通和理解。
异常结果的接收显著增加了焦虑(两组之间的 STAI 平均差异=8.3)。大多数女性的初始焦虑随着时间的推移而降低。然而,12 周时 35%的女性出现了有临床意义的焦虑(即 STAI 评分≥对照组的 0.5 标准差)。这些女性报告社会经济水平较低,不完全理解有关其结果的信息,并认为自己患癌症的风险较高。异常结果后 QALY 的损失在 0.007 至 0.009 之间。
异常涂片结果对心理健康有统计学上显著且具有临床意义的负面影响。然而,对于大多数女性来说,这种负面影响在 12 周后会消退。